August 11, 2014 article Open access Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification Journal of Clinical Oncology DOI: 10.1200/jco.2013.54.8800 Full text (OA) OpenAlex Authors 0 Author list not loaded yet. Cited by 25 stored of 5,747 Search Sort Most cited Newest Oldest Patent citations Title Any typearticle review book-chapter conference-paper preprint dissertation book dataset other Any fieldAgricultural and Biological Sciences Arts and Humanities Biochemistry, Genetics and Molecular Biology Business, Management and Accounting Chemical Engineering Chemistry Computer Science Decision Sciences Dentistry Earth and Planetary Sciences Economics, Econometrics and Finance Energy Engineering Environmental Science Health Professions Immunology and Microbiology Materials Science Mathematics Medicine Neuroscience Nursing Pharmacology, Toxicology and Pharmaceutics Physics and Astronomy Psychology Social Sciences Veterinary Open access CD19 CAR T-cell therapy (GLPG5101) for relapsed or refractory B-cell non-Hodgkin lymphoma (ATALANTA-1): phase 1 results from a single-arm, multicentre, phase 1/2 study 2026 The Lancet Haematology article Medicine CAR-T cell therapy research 0 citations Epcoritamab with rituximab and lenalidomide as first-line treatment for follicular lymphoma (EPCORE NHL-2): an open-label, multicentre, phase 1/2 b trial 2026 The Lancet Haematology article Medicine Lymphoma Diagnosis and Treatment Open access 0 citations First‐line treatment with epcoritamab in combination with bendamustine plus rituximab induces sustained remissions beyond 3 years in patients with follicular lymphoma 2026 HemaSphere article Medicine Lymphoma Diagnosis and Treatment Open access 1 citations Risk of thrombosis and bleeding following CAR T‐cell therapy: Insights from the Dutch “Follow that CAR!” registry 2026 HemaSphere article Medicine CAR-T cell therapy research Open access 0 citations Fixed-duration epcoritamab plus R2 drives favorable outcomes in relapsed or refractory follicular lymphoma 2025 Blood article Medicine Lymphoma Diagnosis and Treatment Open access 14 citations Privacy-Preserving Generation of Structured Lymphoma Progression Reports from Cross-sectional Imaging: A Comparative Analysis of Llama 3.3 and Llama 4 2025 Journal of Imaging Informatics in Medicine article Medicine Artificial Intelligence in Healthcare and Education Open access 4 citations Atezolizumab consolidation in patients with high-risk diffuse large B-cell lymphoma in complete remission after R-CHOP 2025 Blood Advances article Medicine Lymphoma Diagnosis and Treatment Open access 6 citations The evolution of precision oncology: The ongoing impact of the Drug Rediscovery Protocol (DRUP) 2024 Acta Oncologica article Medicine Lung Cancer Treatments and Mutations Open access 24 citations Allogeneic hematopoietic stem-cell transplantation for patients with Richter transformation: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT 2024 Bone Marrow Transplantation article Medicine Hematopoietic Stem Cell Transplantation Open access 10 citations Multi-omic profiling of follicular lymphoma reveals changes in tissue architecture and enhanced stromal remodeling in high-risk patients 2024 Cancer Cell article Medicine Lymphoma Diagnosis and Treatment Open access 72 citations The Dutch CAR-T Tumorboard Experience: Population-Based Real-World Data on Patients with Relapsed or Refractory Large B-Cell Lymphoma Referred for CD19-Directed CAR T-Cell Therapy in The Netherlands 2023 Cancers article Medicine CAR-T cell therapy research Open access 23 citations Inflammatory reactions mimic residual or recurrent lymphoma on [18F]FDG-PET/CT after CD19-directed CAR T-cell therapy 2023 Blood Advances article Medicine CAR-T cell therapy research Open access 14 citations PET/CT in Hodgkin Lymphoma: An Update 2022 Seminars in Nuclear Medicine article Medicine Lymphoma Diagnosis and Treatment 37 citations Central venous catheter–associated complications in pediatric patients diagnosed with Hodgkin lymphoma: implications for catheter choice 2022 Supportive Care in Cancer article Health Professions Central Venous Catheters and Hemodialysis Open access 24 citations Twenty Years On: RECIST as a Biomarker of Response in Solid Tumours an EORTC Imaging Group – ESOI Joint Paper 2022 Frontiers in Oncology article Medicine Medical Imaging Techniques and Applications Open access 56 citations Bone Metastases Are Measurable: The Role of Whole-Body MRI and Positron Emission Tomography 2021 Frontiers in Oncology article Medicine Medical Imaging Techniques and Applications Open access 45 citations Primary cutaneous lymphoma: recommendations for clinical trial design and staging update from the ISCL, USCLC, and EORTC 2021 Blood article Medicine Cutaneous lymphoproliferative disorders research Open access cited by 1 patent 184 citations Comparison of the Effectiveness and Safety of the Oral Selective Inhibitor of Nuclear Export, Selinexor, in Diffuse Large B Cell Lymphoma Subtypes 2021 Clinical Lymphoma Myeloma & Leukemia article Medicine Lymphoma Diagnosis and Treatment Open access 9 citations Positron emission tomography/computed tomography in the management of Hodgkin and B‐cell non‐Hodgkin lymphoma: An update 2021 Cancer article Medicine Lymphoma Diagnosis and Treatment Open access 30 citations 18F-Fluorothymidine PET is an early and superior predictor of progression-free survival following chemoimmunotherapy of diffuse large B cell lymphoma: a multicenter study 2021 European Journal of Nuclear Medicine and Molecular Imaging article Medicine Lymphoma Diagnosis and Treatment Open access 14 citations 1–20 of 25 Page 1 / 2 Next → References 0